Open Mobile Menu About UsManagementBoard of DirectorsCareersNewsEventsResourcesCOVID-19 ResponseContact News For media inquiries: media@codexis.com YEAR November 22, 2021 05:00 AM Codexis Presents Pre-Clinical Data Highlighting its Programs in Homocystinuria and Maple Syrup Urine Disease at ICIEM 2021 November 15, 2021 05:00 AM Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development November 4, 2021 01:05 PM Codexis Reports Third Quarter 2021 Financial Results November 4, 2021 05:00 AM The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc. November 3, 2021 01:05 PM Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency October 18, 2021 05:00 AM Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India September 9, 2021 01:05 PM Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin August 25, 2021 01:05 PM Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company August 5, 2021 01:05 PM Codexis Reports Second Quarter 2021 Financial Results July 26, 2021 01:05 PM Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient July 14, 2021 01:05 PM Codexis Announces Completion of CodeEvolver® License Technology Transfer with Global Pharmaceutical Leader July 7, 2021 01:05 PM Codexis Earns Milestone Payment from GlaxoSmithKline June 17, 2021 01:44 PM Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme Product June 10, 2021 04:00 AM Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic Disorder May 6, 2021 01:05 PM Codexis Reports First Quarter 2021 Financial Results February 25, 2021 01:05 PM Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results February 9, 2021 01:05 PM Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth February 3, 2021 01:05 PM Codexis Appoints Dr. Esther Martinborough to its Board of Directors January 13, 2021 04:00 AM Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle’s Stevia and Allulose Production December 2, 2020 08:10 PM Codexis Announces Pricing of Public Offering of Common Stock November 24, 2020 02:01 PM Codexis and Casdin Capital Launch SynBio Innovation Accelerator November 5, 2020 01:05 PM Codexis Reports Third Quarter 2020 Financial Results August 6, 2020 04:00 AM Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors August 1, 2020 01:05 PM Codexis Reports Second Quarter 2020 Financial Results June 23, 2020 04:00 AM Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis June 16, 2020 01:05 PM Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders June 1, 2020 01:05 PM Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets May 7, 2020 01:05 PM Codexis Reports First Quarter 2020 Financial Results May 6, 2020 01:05 PM Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader May 5, 2020 04:00 AM Codexis Expands and Strengthens its Leadership Team with Two Executive Hires March 23, 2020 04:00 AM Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders February 27, 2020 01:05 PM Codexis Reports 2019 Fourth Quarter and Full Year Financial Results January 10, 2020 04:00 AM Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement December 23, 2019 04:00 AM Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing December 5, 2019 01:05 PM Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir October 15, 2019 01:05 PM Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field August 6, 2019 01:04 PM Codexis Names Ross Taylor Senior Vice President and Chief Financial Officer June 20, 2019 04:00 AM Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives May 15, 2019 06:00 AM Codexis Announces CodeEvolver® Technology Transfer and License Agreement with Global Pharmaceutical Leader April 30, 2019 04:00 AM Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener February 26, 2019 01:05 PM Codexis Reports 2018 Fourth Quarter and Full Year Financial Results February 14, 2019 04:00 AM Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria February 6, 2019 04:00 AM Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan February 4, 2019 01:05 PM Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck November 8, 2018 04:00 AM Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114 April 23, 2018 03:00 AM Porton Pharma Solutions and Codexis Launch Global Partnership twitter linkedin CONTACTINVESTORSCAREERSTERMS OF SALETRADEMARKSPATENTSTERMS OF USEPRIVACY © 2021 Codexis. All rights reserved.